Literature DB >> 11709653

Physiologic basis for the treatment of pulmonary hypertension.

H Olschewski1, A Olschewski, F Rose, R Schermuly, H Schütte, N Weissmann, W Seeger, F Grimminger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11709653     DOI： 10.1067/mlc.2001.119329

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN： 0022-2143


× No keyword cloud information.
  9 in total

Review 1.  Erythrocyte-derived ATP and perfusion distribution: role of intracellular and intercellular communication.

Authors:  Randy S Sprague; Mary L Ellsworth
Journal:  Microcirculation       Date:  2012-07       Impact factor: 2.628

2.  5(th) Asian PAD Workshop.

Authors: 
Journal:  Ann Vasc Dis       Date:  2014

3.  Persistence of complex vascular lesions despite prolonged prostacyclin therapy of pulmonary arterial hypertension.

Authors:  Jennifer E Pogoriler; Stuart Rich; Stephen L Archer; Aliya N Husain
Journal:  Histopathology       Date:  2012-10       Impact factor: 5.087

4.  Acute improvement of pulmonary hemodynamics does not alleviate Cheyne-Stokes respiration in chronic heart failure-a randomized, controlled, double-blind, crossover trial.

Authors:  Thomas Bitter; Henrik Fox; Heidi Schmalgemeier; Birgit Wellmann; Andrea Zwenke; Jens Spiesshöfer; Zisis Dimitriadis; Dieter Horstkotte; Olaf Oldenburg
Journal:  Sleep Breath       Date:  2016-01-19       Impact factor: 2.816

Review 5.  [Pulmonary hypertension. Pathophysiology and current concepts of medication therapy].

Authors:  H Wilkens
Journal:  Anaesthesist       Date:  2004-08       Impact factor: 1.041

6.  Inhaled tolafentrine reverses pulmonary vascular remodeling via inhibition of smooth muscle cell migration.

Authors:  Soni Pullamsetti; Stefanie Krick; Hüseyin Yilmaz; Hossein Ardeschir Ghofrani; Christian Schudt; Norbert Weissmann; Beate Fuchs; Werner Seeger; Friedrich Grimminger; Ralph Theo Schermuly
Journal:  Respir Res       Date:  2005-11-01

Review 7.  Revisiting the Large-Conductance Calcium-Activated Potassium (BKCa) Channels in the Pulmonary Circulation.

Authors:  Divya Guntur; Horst Olschewski; Péter Enyedi; Réka Csáki; Andrea Olschewski; Chandran Nagaraj
Journal:  Biomolecules       Date:  2021-11-03

Review 8.  New progress in diagnosis and treatment of pulmonary arterial hypertension.

Authors:  Zai-Qiang Zhang; Sheng-Kui Zhu; Man Wang; Xin-An Wang; Xiao-Hong Tong; Jian-Qiao Wan; Jia-Wang Ding
Journal:  J Cardiothorac Surg       Date:  2022-08-29       Impact factor: 1.522

9.  Vasodilatory effect of the stable vasoactive intestinal peptide analog RO 25-1553 in murine and rat lungs.

Authors:  Jun Yin; Liming Wang; Ning Yin; Arata Tabuchi; Hermann Kuppe; Gerhard Wolff; Wolfgang M Kuebler
Journal:  PLoS One       Date:  2013-09-19       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.